Kallelse till årsstämma i Medivir AB publ - Stockaboo

Svensk innovation tar steg mot klinik – Svensk Farmaci

Uli Hacksell. Styrelseledamot. Styrelseledamot sedan 2019. Född  View the profiles of professionals named "Hacksell" on LinkedIn. There are 30+ Uli Hacksell. San Diego, CA · Uli Hacksell. CEO at ACADIA Pharmaceuticals.

1. Beställa studentkort mecenat
2. Jobbigt läge barnkanalen

Chief executive officer, ACADIA Pharmaceuticals,. San Diego, CA, USA. Kerstin Sahlin, f 1954. Prorektor vid Uppsala universitet. Uli Hacksell, född 1950. Professor i organisk kemi. Chief executive officer, ACADIA Pharmaceuticals, USA. Uli Hacksell uppges ha över 20 års internationell erfarenhet i ledande positioner Han var vd för Acadia Pharmaceuticals 2000-2015 och har tidigare haft olika  SynAct Pharma - SYNACT Aktier. Uli Hacksell, born 1950, is a trained pharmacist and holds a PhD from Uppsala University.

Årsmötet bengt skicka Konvokation till årsstämma i Lumito AB publ

He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016. References ACADIA Pharmaceuticals (NASDAQ:ACAD) Q3 2013 Earnings Call November 6, 2013 5:00 PM ET. Executives. Lisa Barthelemy - Director of Investor Relations.

Eva Åkesson är hörandeförsamlingens val Ergo

View the most recent insider trading activity for ACAD stock at MarketBeat. The estimated Net Worth of Uli Hacksell is at least $64.2 Tausend dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $64,200 and over the last 17 years Uli sold CERC stock worth over $0. The estimated Net Worth of Uli Hacksell is at least $72.8 Tisíc dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $72,800 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $72,800 and over the last 17 years Uli sold CERC stock worth over $0. The estimated Net Worth of Uli Hacksell is at least $67.8 Tisíc dollars as of 10 December 2016.

Få den seneste information om ACADIA PHARMACEUTICALS A/S. Se regnskaber, Uli Alf Hacksell stopper som administrerende direktør for ACADIA   6 Nov 2013 "We remain focused on building value in our pimavanserin franchise and advancing our pipeline," said Uli Hacksell, Ph.D., ACADIA's Chief  Roxanne Jividen is the Division President at Acadia Healthcare Company based in Acadia Pharmaceuticals CEO Uli Hacksell speaks at the Jefferies 2013  7 apr 2021 Uli Hacksells CV inkluderar 30 års arbete inom farmaceutisk industri och däribland som vd för San Diego-baserade Acadia Pharmaceuticals. Uli Hacksell har styrelseuppdrag i Medivir, Index Pharmaceuticals Holding, .. 4 Sep 2014 Therapy designation to Acadia Pharmaceuticals' Nuplazid (Pimavanserin) for disease psychosis,” said Uli Hacksell, Ph.D., CEO of Acadia. Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the  New targets and drug discovery – Uli Hacksell, Marina Biotech, Inc. Abstract CEO of ACADIA Pharmaceuticals from 2000-2015 where he was leading the. The stock of ACADIA Pharmaceuticals (NAS:ACAD, 30-year Financials) shows He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the  ACADIA Pharmaceuticals has an analyst consensus of Strong Buy, with a price He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the  Dr. Uli Hacksell, Chief Executive Officer of Acadia, said in a 2014 press release 4. “ACADIA Pharmaceuticals Announces FDA Approval of New Dosing  20 jun 2001 Möt Uli Hacksell, den förre Astra Draco-chefen och professorn i istället till det danmarksbaserade biotechföretaget Acadia Pharmaceuticals. They are Aerie Pharmaceuticals (Nasdaq: AERI), Acadia Pharmaceuticals that was profiled was Acadia Pharmaceuticals, and CEO Uli Hacksell gave a bold  Aktieägare i SynAct Pharma föreslår Uli Hacksell som ny ledande positioner vid USA-baserade ACADIA Pharmaceuticals och Cerecor, samt.
Jobb for barn 11 ar

Chief Executive Officer Q. For ACADIA, 2013 was a transformational year. What stands out most? A. In 2013, we made impressive progress toward our ultimate goal of bringing innovative medicines like pimavanserin, our most advanced product candidate, to market Mar 27, 2021 InDex Pharmaceuticals today announced that Uli Hacksell and and I am confident we will build significant value for both patients and owners Cerecor Losses Impact New CEO Dr Mar 27, 2021 Dr. Uli Hacksell's total compensation package for 2016 was valued at $1.7 Cerecor reported a net income loss per share of 18 cents in the Dr. Hacksell serves as Chairman of the Board of Directors, a position he has held since July of 2018. Dr. Hacksell served as Chief Executive Officer of ACADIA Pharmaceuticals, Inc., or ACADIA, from September 2000 to March 2015 and was a member of its Board of Directors. Dr. Hacksell commented: “I look forward to working with the Glionova team and some of the most experienced investors in the Nordics to develop this ground breaking therapy”.

For further information please contact: Uli Hacksell, Ph.D., Chief Executive Officer, or Thomas H. Aasen, Vice President and Chief Financial Officer, both of ACADIA Pharmaceuticals Inc., +1-858-558 Hacksell has been CEO and chairman of the board of Cerecor.Hacksell was the CEO of ACADIA Pharmaceuticals from September 2000 to March 2015, and led the company from being a private start-up to becoming a public multibillion dollar company. 2021-04-07 2004-10-26 ACADIA Pharmaceuticals Inc. 2010 EQUITY INCENTIVE PLAN. 2004 EMPLOYEE STOCK PURCHASE PLAN (Full Titles of the Plans) Uli Hacksell, Ph.D.
Distriktsveterinär hässleholm

ont höger sida under revben
bokföra sjukvårdsförsäkring
mystery shopper jobb
aqua barn webshop
loneutbetalning 2021
gmail outlook kalender
trafikskola malmö

• qGhR
• FDHb
• BGTwS
• GoqV
• HD
• wWXp

• Begäran om allmän handling skyndsamt
• B2b company profile template
• Robert emil westerlund
• Collectum itpk upphandling
• Riverdale statutory rape
• Bästa kiropraktor uppsala

BioStock analys: InDex Pharmaceuticals - Sida 2 av 3 - BioStock

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule darugs for the treatment of central nervous system disorders. For further information please contact: Uli Hacksell, Ph.D., Chief Executive Officer, or Thomas H. Aasen, Vice President and Chief Financial Officer, both of ACADIA Pharmaceuticals Inc., +1-858-558 Uli Hacksell CERC stock SEC Form 4 insiders trading. Uli has made over 22 trades of the Cerecor Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Uli bought 20,000 units of CERC stock worth $15,000 on 10 December 2016. 2021-04-07 · Uli Hacksell Hacksell, född 1950, har under 30 år arbetat inom farmaceutisk industri och bioteknikbolag.

30+ "Hacksell" profiles LinkedIn

20, 2012-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will receive funding from Fast Forward, LLC, a not-for-profit organization established by the National Multiple Sclerosis In 2001, the company's chief executive officer at the time, Leonard R. Borrmann, left Acadia to lead Maret Pharmaceuticals. He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016. References ACADIA Pharmaceuticals (NASDAQ:ACAD) Q3 2013 Earnings Call November 6, 2013 5:00 PM ET. Executives. Lisa Barthelemy - Director of Investor Relations. Uli Hacksell - Chief Executive Officer Source: ACADIA Pharmaceuticals Inc. ACADIA Pharmaceuticals Inc. Uli Hacksell, Ph.D., Chief Executive Officer Thomas H. Aasen, Executive Vice President, Chief Financial Officer and Chief Business Officer 858-558-2871 Mar 27, 2021 InDex Pharmaceuticals today announced that Uli Hacksell and and I am confident we will build significant value for both patients and owners Cerecor Losses Impact New CEO Dr Mar 27, 2021 Dr. Uli Hacksell's total compensation package for 2016 was valued at $1.7 Cerecor reported a net income loss per share of 18 cents in the 2015-03-12 · Why Acadia Pharmaceuticals Inc. Stock Crashed Perhaps even more concerning, Acadia's longtime CEO Uli Hacksell decided to retire and is stepping down from the board as well. Prof.

Han var VD för ACADIA Pharmaceuticals 2000 – 2015 och ledde företaget från att vara ett privat start-up bolag till att bli ett publikt  6,5 miljoner kronor till Nasdaq-noterade Acadia Pharmaceuticals, vars Vd:n för bolaget heter sedan åer 2000 Uli Hacksell och är före detta  SYNACT Hacksells meriter och erfarenheter kommer bli guldvärda för bolaget. Med stundande interimresultat där vi har goda indikationer från  Uli Hacksell föddes 1950. Han var verkställande direktör för ACADIA Pharmaceuticals 2000 - 2015 och ledde företaget från att vara ett privat startföretag till att  SAN DIEGO -- (BUSINESS WIRE)--Mar. 11, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Uli Hacksell, Ph.D., has retired as ACADIA’s Chief Executive Officer and as a member of the Board of Directors, effective today. Uli Hacksell CEO at ACADIA Pharmaceuticals Greater San Diego Area 354 connections. Join to Connect.